Artemisinin resistance in Plasmodium falciparum: What is it really?

Trends in Parasitology

Volumn 29, Issue 7, 2013, Pages 318-320

  Ferreira, Pedro Eduardo ^a,b,c   Culleton, Richard ^a   Gil, Jose Pedro ^c,d   Meshnick, Steven Richard ^e  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF ALGARVE   (Portugal)

^c KAROLINSKA INSTITUTE   (Sweden)

^d BINGHAMTON UNIVERSITY   (United States)

^e University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ;

CLINICAL EFFECTIVENESS; DRUG CLEARANCE; DRUG RESPONSE; HUMAN; IN VITRO STUDY; MALARIA FALCIPARUM; NONHUMAN; PARASITOLOGY; PLASMODIUM FALCIPARUM; PROBABILITY; REVIEW; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 84879464213     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.05.002     Document Type: Review

References (24)

1. White N.J. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 1999, 41:301-308.
2. Price R.N., et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996, 347:1654-1658.
3. Yeung S., et al. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. 2004, 71:179-186.
4. Noedl H., et al. Evidence of artemisinin-resistant malaria in Western Cambodia. N. Engl. J. Med. 2008, 359:2619-2620.
5. Dondorp A.M., et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
6. Khamsiriwatchara A., et al. Artemisinin resistance containment project in Thailand. (I): Implementation of electronic-based malaria information system for early case detection and individual case management in provinces along the Thai-Cambodian border. Malar. J. 2012, 11:247.
7. Miotto O., et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat. Genet. 2013, 45:648-655.
8. Cheeseman I.H., et al. A major genome region underlying artemisinin resistance in malaria. Science 2012, 336:79-82.
9. Meshnick S.R., et al. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 1996, 60:301-315.
10. Klonis N., et al. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5157-5162.
11. Saralamba S., et al. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:397-402.
12. Wilting R.H., Dannenberg J.H. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resist. Updat. 2012, 15:21-38.
13. Takala-Harrison S., et al. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:240-245.
14. Mok S., et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 2011, 12:391.
15. Stepniewska K., et al. In vivo parasitological measures of artemisinin susceptibility. J. Infect. Dis. 2010, 201:570-579.
16. Saunders D., et al. Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in Western Cambodia. Antimicrob. Agents Chemother. 2012, 56:5484-5493.
17. Nguyen D.S., et al. Treatment of malaria in Vietnam with oral artemisinin. Am. J. Trop. Med. Hyg. 1993, 48:398-402.
18. Ittarat W., et al. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am. J. Trop. Med. Hyg. 2003, 68:147-152.
19. White N.J. Antimalarial drug resistance. J. Clin. Invest. 2004, 113:1084-1092.
20. Kremsner P.G., Krishna S. Antimalarial combinations. Lancet 2004, 364:285-294.
21. Nosten F., et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 1994, 170:971-977.
22. Ferreira P.E., Culleton R. Dynamics of Plasmodium falciparum selection after artemether-lumefantrine treatment in Africa. J. Infect. Dis. 2012, 205:1473-1475.
23. Malmberg M., et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J. Infect. Dis. 2013, 207:842-847.
24. Noedl H. Artemisinin resistance: how can we find it?. Trends Parasitol. 2005, 21:404-405.